Acute kidney injury (AKI) is associated with high mortality in native kidneys, decreased allograft survival in transplants, and very high health care cost. Among the most common etiologies of AKI in both native and transplanted kidneys is ischemia-reperfusion injury (IRI). There is currently no specific therapy for AKI and the recovery process is incompletely understood. A major unknown is precise roles of each T cell type. This is important as some T cells are involved in causing AKI, whereas others are involved in preventing tissue damage and improving repair. Our team is focusing on characterizing and understanding the role of double negative (DN) ?? T cells in healthy kidney and during AKI. DN T cells are one of the least understood T cell types because of their paucity in peripheral lymphoid organs and thus have been relatively ignored. However, we recently discovered DNT cells as a large constituent of kidney ??T cells (hereafter referred to as KDNT cells). Significance of KDNT cells is underscored by their proven suppressive functions in vitro and immunoregulatory protective function during experimental AKI. This renewal application is based on strong recently published and unpublished preliminary data showing that KDNT cells are divided into two (PD-1+ and NK1.1+) subsets in murine and human kidney. Murine PD-1+ DNT cells are actively dividing in the steady state that is accompanied by a proliferative burst in response to experimental IRI by mechanisms that are not restricted by known classical or non-classical MHC I and II molecules. The non-dividing NK1.1+ subset is regulated by ?2m-dependent non-classical MHC class I in mice. The major goals of this renewal application are to investigate the regulatory role of PD-1 molecule, relationship of KDNT cells and renal tubular epithelial cells (RTEC) in health and AKI, and translational of our murine findings to humans using human kidney samples and from discarded deceased donors.
Our specific Aims : Test the hypothesis that PD-1/PD-L system regulates homeostasis and effector function of kidney DN T cells in health and AKI. 2) Test the hypothesis that kidney DN and TREC regulate each other via a bidirectional loop during health and AKI. 3) Test the hypothesis that human KDNT cells are suppresser cells that regulate homeostasis of RTEC during health and AKI. We have all the key critical elements to achieve these goals that include an in vitro KDNT/RTEC culture system, unique access to human kidney samples pre and post ischemia (from nephrectomies) and discarded deceased donor kidneys, and a synergistic team of investigators with an established collaborative track record and complementary expertise needed for successful outcome.

Public Health Relevance

Acute kidney injury (AKI) is associated with high mortality in native kidneys, decreased allograft survival in transplants, and very high health care costs. AKI is emerging as a serious side effect of checkpoint inhibitor immunotherapy for cancer. Double negative T cells that reside in the kidney play important role in protecting hosts against AKI as demonstrated in our mouse studies. The proposed preclinical studies in mice and translational studies with human kidney DN T cells are expected to provide novel insights that can lead to new therapeutics for AKI.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK104662-07
Application #
10106617
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Schulman, Ivonne Hernandez
Project Start
2015-03-01
Project End
2024-02-28
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
7
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Pathology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Lee, Sul A; Cozzi, Martina; Bush, Errol L et al. (2018) Distant Organ Dysfunction in Acute Kidney Injury: A Review. Am J Kidney Dis 72:846-856
Lee, Sul A; Noel, Sanjeev; Sadasivam, Mohanraj et al. (2018) Characterization of kidney CD45intCD11bintF4/80+MHCII+CX3CR1+Ly6C- ""intermediate mononuclear phagocytic cells"". PLoS One 13:e0198608
Lee, Sul A; Noel, Sanjeev; Sadasivam, Mohanraj et al. (2017) Role of Immune Cells in Acute Kidney Injury and Repair. Nephron 137:282-286
Martina, Maria N; Noel, Sanjeev; Saxena, Ankit et al. (2016) Double-Negative ?? T Cells Are Early Responders to AKI and Are Found in Human Kidney. J Am Soc Nephrol 27:1113-23
Noel, Sanjeev; Desai, Niraj M; Hamad, Abdel Rahim A et al. (2016) Sex and the single transplanted kidney. J Clin Invest 126:1643-5
Noel, Sanjeev; Martina, Maria N; Bandapalle, Samatha et al. (2015) T Lymphocyte-Specific Activation of Nrf2 Protects from AKI. J Am Soc Nephrol 26:2989-3000
Dai, Hong; Rahman, Ayesha; Saxena, Ankit et al. (2015) Syndecan-1 identifies and controls the frequency of IL-17-producing naïve natural killer T (NKT17) cells in mice. Eur J Immunol 45:3045-51
Noel, Sanjeev; Hamad, Abdel R A; Rabb, Hamid (2015) Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases. Kidney Int 88:1217-1218
Martina, Maria N; Noel, Sanjeev; Saxena, Ankit et al. (2015) Double negative (DN) ?? T cells: misperception and overdue recognition. Immunol Cell Biol 93:305-10
Martina, M N; Noel, S; Bandapalle, S et al. (2014) T lymphocytes and acute kidney injury: update. Nephron Clin Pract 127:51-5